NCT00308074 An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders Status COMPLETED Phase PHASE2
NCT00306878 Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris Status COMPLETED Phase PHASE1
NCT00306202 Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia Status COMPLETED Phase PHASE1
NCT00305201 Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease Status WITHDRAWN Phase PHASE2
NCT00300027 Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies Status TERMINATED Phase PHASE1
NCT00298987 A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate Status COMPLETED Phase PHASE2
NCT00298467 MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma Status WITHDRAWN Phase PHASE2
NCT00296803 PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT00296218 ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation Status COMPLETED Phase PHASE3
NCT00295282 A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT00292955 Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Status UNKNOWN Phase PHASE2
NCT00291707 Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00289640 Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma Status COMPLETED Phase PHASE2
NCT00289627 A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma Status COMPLETED Phase PHASE2
NCT00287547 Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris Status COMPLETED Phase PHASE2
NCT00284804 A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease Status COMPLETED Phase PHASE2
NCT00284180 Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00284154 Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer Status COMPLETED Phase PHASE2